Characteristics of patients who underwent two-stage reconstruction

A	B	C	D	E	F	G	H	I	J
1	M/63	primary THA	AML stem	No	96	late chronic	6	S. aureus	69
2	F/58	primary THA	AML stem	No	146	late chronic	13	Culture neg.	24
3	F/31	stem revision	Corail stem	I & D	7	acute hematogenous	4	S. aureus	31
4	M/39	primary THA	CLS stem	I & D	85	late chronic	8	CNS	39
5	F/64	primary THA	Euroform stem	No	62	late chronic	24	S. aureus	24
6	F/69	primary THA	Corail stem	No	6	acute hematogenous		Streptococci	10
7	M/56	HA	CLS stem	I & D	216	late chronic	9	S. aureus	71
8	F/36	primary THA	AML stem	I & D	39	late chronic	3	Culture neg.	100
9	F/56	total revision	Bicontact stem	I & D	13	late chronic	15	Culture neg.	88
10	F/37	primary THA	Gemini stem	No	173	late chronic	7	S. aureus	51
11	M/53	primary THA	Corail stem	No	6	acute hematogenous	4	CNS	Recurred
12	M/59	primary THA	Anatomical 6° stem	No	144	acute hematogenous	7	Streptococci	Recurred
13	F/74	HA	Summit stem	No	9	late chronic	3	S. aureus	26
14	M/85	HA	Summit stem	No	9	acute hematogenous	2	Enterococci	26
15	F/74	HA	Summit stem	No	9	acute hematogenous	1	CNS	43
16	M/51	cup revision	Bicontact stem	No	19	acute hematogenous	4	CNS	26
17	F/84	HA	Bencox II stem	No	38	acute hematogenous	2	Culture neg	24
18	F/79	HA	Soma stem	No	36	acute hematogenous		S. aureus	25
19	F/77	HA	Wagner stem	I & D	72	late chronic	2	CNS	40

THA: total hip arthroplasty; HA: hemiarthroplasty; I & D: incision and debridement; CNS: coagulase-negative Staphylococcus.

A Patient no.

B Sex/age

C Type of index arthroplasty

D Previous stem

E Previous treatment

F Interval between index arthroplasty and first-stage revision (months)

G Type of Infection

H Interval between procedures (months)

I Etiological organism

F Duration of follow-up (months)